Insider Transactions in Q2 2021 at Dicerna Pharmaceuticals Inc (DRNA)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 25
2021
|
Regina M. Paglia Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
1,000
-78.8%
|
$38,000
$38.0 P/Share
|
|
Jun 25
2021
|
Regina M. Paglia Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+44.07%
|
$22,000
$22.58 P/Share
|
|
Jun 22
2021
|
Regina M. Paglia Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
18,435
-83.62%
|
$663,660
$36.9 P/Share
|
|
Jun 22
2021
|
Regina M. Paglia Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,435
+24.39%
|
$350,265
$19.85 P/Share
|
|
Jun 17
2021
|
Regina M. Paglia Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
8,664
-96.99%
|
$303,240
$35.79 P/Share
|
|
Jun 17
2021
|
Regina M. Paglia Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,664
+39.76%
|
$155,952
$18.49 P/Share
|
|
Jun 16
2021
|
Regina M. Paglia Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
31,564
-62.97%
|
$1,104,740
$35.89 P/Share
|
|
Jun 16
2021
|
Regina M. Paglia Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,564
+26.39%
|
$631,280
$20.71 P/Share
|
|
Jun 15
2021
|
Regina M. Paglia Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
112
-29.4%
|
$3,920
$35.74 P/Share
|
|
Jun 15
2021
|
Regina M. Paglia Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
381
+50.0%
|
-
|
|
Jun 15
2021
|
Douglas W. Pagan Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,004
-25.81%
|
$70,140
$35.74 P/Share
|
|
Jun 15
2021
|
Douglas W. Pagan Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,825
+46.78%
|
-
|
|
Jun 14
2021
|
Robert D. Ciappenelli Chief Strategy Officer |
SELL
Open market or private sale
|
Direct |
20,000
-84.13%
|
$760,000
$38.0 P/Share
|
|
Jun 14
2021
|
Robert D. Ciappenelli Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+45.69%
|
$300,000
$15.61 P/Share
|
|
Jun 11
2021
|
Robert D. Ciappenelli Chief Strategy Officer |
SELL
Open market or private sale
|
Direct |
10,000
-72.61%
|
$350,000
$35.0 P/Share
|
|
Jun 11
2021
|
Robert D. Ciappenelli Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+42.06%
|
$150,000
$15.61 P/Share
|
|
Jun 11
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
SELL
Open market or private sale
|
Direct |
10,000
-31.73%
|
$340,000
$34.0 P/Share
|
|
Jun 11
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+24.09%
|
$90,000
$9.09 P/Share
|
|
Jun 07
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
SELL
Open market or private sale
|
Direct |
10,000
-31.73%
|
$330,000
$33.0 P/Share
|
|
Jun 07
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+24.09%
|
$90,000
$9.09 P/Share
|
|
Jun 03
2021
|
Adam Koppel Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,333
+50.0%
|
-
|
|
Jun 03
2021
|
Stephen K Doberstein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,333
+50.0%
|
-
|
|
Jun 03
2021
|
Patrick M. Gray Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,333
+50.0%
|
-
|
|
Jun 03
2021
|
J Kevin Buchi Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,666
+50.0%
|
-
|
|
Jun 03
2021
|
Anna Protopapas Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,333
+50.0%
|
-
|
|
Jun 03
2021
|
Martin I Freed Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,333
+50.0%
|
-
|
|
Jun 03
2021
|
Marc D Kozin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,333
+50.0%
|
-
|
|
Jun 03
2021
|
Cynthia Smith Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,333
+50.0%
|
-
|
|
Jun 03
2021
|
Stephen J Hoffman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,333
+10.29%
|
-
|
|
Jun 01
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
SELL
Open market or private sale
|
Direct |
8,312
-14.14%
|
$257,672
$31.45 P/Share
|
|
Jun 01
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
8,312
+21.79%
|
$24,936
$3.42 P/Share
|
|
Jun 01
2021
|
Regina M. Paglia Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
4,431
-96.56%
|
$137,361
$31.42 P/Share
|
|
Jun 01
2021
|
Regina M. Paglia Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,431
+50.0%
|
$53,172
$12.93 P/Share
|
|
May 03
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
SELL
Open market or private sale
|
Direct |
8,312
-9.7%
|
$249,360
$30.94 P/Share
|
|
May 03
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
8,312
+21.79%
|
$24,936
$3.42 P/Share
|
|
May 03
2021
|
Regina M. Paglia Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
4,431
-94.64%
|
$132,930
$30.71 P/Share
|
|
May 03
2021
|
Regina M. Paglia Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,431
+50.0%
|
$53,172
$12.93 P/Share
|
|
Apr 30
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
SELL
Open market or private sale
|
Direct |
10,000
-31.73%
|
$320,000
$32.0 P/Share
|
|
Apr 30
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+24.09%
|
$90,000
$9.09 P/Share
|
|
Apr 29
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
SELL
Open market or private sale
|
Direct |
10,000
-31.73%
|
$310,000
$31.0 P/Share
|
|
Apr 29
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+24.09%
|
$90,000
$9.09 P/Share
|
|
Apr 16
2021
|
James B Weissman Chief Operating Officer & EVP |
SELL
Open market or private sale
|
Direct |
4,904
-23.46%
|
$142,216
$29.99 P/Share
|
|
Apr 01
2021
|
Regina M. Paglia Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
4,431
-100.0%
|
$110,775
$25.86 P/Share
|
|
Apr 01
2021
|
Regina M. Paglia Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,431
+50.0%
|
$53,172
$12.93 P/Share
|
|
Apr 01
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
SELL
Open market or private sale
|
Direct |
8,312
-14.05%
|
$216,112
$26.18 P/Share
|
|
Apr 01
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
8,312
+21.79%
|
$24,936
$3.42 P/Share
|